New Drugs & OTCs

06/15/2011 - 1:42pm
Nasacort AQ generic enters market

Teva Pharmaceutical Industries has begun shipping a generic drug for allergies, partnering company Perrigo said Wednesday.

06/15/2011 - 1:10pm
Tradjenta now available in U.S. pharmacies

A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

06/15/2011 - 10:58am
Watson confirms patent challenge for generic Pataday

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for a generic drug for eye disease, the company said Tuesday.

06/14/2011 - 11:15am
FDA OKs infant-specific dose of Creon

The Food and Drug Administration has approved a new dosage of a drug made by Abbott for treating cystic fibrosis in infants, the drug maker said Tuesday.

06/14/2011 - 11:07am
Bayer Advanced Aspirin officially launches

Bayer on Tuesday introduced its new Bayer Advanced Aspirin, billed as relieving pain “twice as fast” as the previous Extra Strength Bayer Aspirin.

06/14/2011 - 10:01am
Cypress gets OK for cough-cold medications Zutripro, Rezira

The Food and Drug Administration has approved two cough-cold medications made by Cypress Pharmaceutical, the company said Monday.

06/14/2011 - 9:33am
XRP Energy gears up for nationwide launch

Top Five Labs on Monday announced its intent to expand distribution of its XRP Energy product — endorsed by former National Football League quarterback Brett Favre — nationwide after a successful test launch in select convenience stores and marts throughout Alabama, Mississippi, Florida, Wisconsin and Minnesota.

06/13/2011 - 1:32pm
PhRMA: More than 260 medicines in development to treat skin diseases

More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

06/13/2011 - 11:21am
BluScience supplement line to be sold at GNC

ChromaDex on Monday announced it will launch a supplement line in GNC called BluScience in July.

06/13/2011 - 11:04am
GSK, Valeant receive FDA approval for Potiga

The Food and Drug Administration has approved a new drug for epilepsy made by GlaxoSmithKline and Valeant Pharmaceuticals International, the drug makers said Monday.

© 2013 Drug Store News. All Rights Reserved.